Metabolic Research Peptides
Compounds in this category are studied for their activity at incretin receptors — principally GLP-1, GIP, and glucagon receptor pathways — and their downstream effects on glucose regulation and energy metabolism in preclinical models. This is the most heavily published area of peptide research in the last decade.
Low stockSemaglutide
5–20mg · ≥99% pure
Long-acting GLP-1 receptor agonist studied extensively for incretin pathway signaling and glucose regulation in preclinical models.
- CAS
- 910463-68-2
- MW
- 4113.58
- Purity
- ≥99%
Tirzepatide
10–30mg · ≥99% pure
Dual GIP and GLP-1 receptor agonist — a 39-amino-acid synthetic peptide studied for combined incretin pathway activity.
- CAS
- 2023788-19-2
- MW
- 4813.45
- Purity
- ≥99%
Low stockRetatrutide
10–30mg · ≥99% pure
Triple agonist at GIP, GLP-1, and glucagon receptors — among the most actively studied compounds in current metabolic research.
- CAS
- 2381089-83-2
- MW
- 4731.32
- Purity
- ≥99%
Cagrilintide
10mg · ≥99% pure
Long-acting amylin analog studied at calcitonin and amylin receptors — a satiety pathway mechanistically distinct from incretin agonism.
- CAS
- 1415456-99-3
- MW
- 4409
- Purity
- ≥99%
AOD-9604
5mg · ≥99% pure
C-terminal fragment of human growth hormone studied for lipolytic activity without the growth-promoting effects of the full hormone.
- CAS
- 221231-10-3
- MW
- 1815.08
- Purity
- ≥99%
Other research areas